IMP
Process View
regulation of chemokine mediated signaling pathway
Any process that modulates the rate, frequency or extent of the series of molecular events generated as a consequence of a chemokine binding to a cell surface receptor.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of chemokine mediated signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CCR5 | chemokine (C-C motif) receptor 5 | 1.000 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.992 | Human | |
| CCL2 | chemokine (C-C motif) ligand 2 | 0.970 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.965 | ||
| IL8 | interleukin 8 | 0.942 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.905 | Human | |
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.870 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.847 | ||
| IL1B | interleukin 1, beta | 0.835 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.802 | Human | |
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.760 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.624 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.623 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.524 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.514 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.512 | Human | |
| IDE | insulin-degrading enzyme | 0.449 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.390 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.274 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.194 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.180 | Human | |
| RGS1 | regulator of G-protein signaling 1 | 0.178 | ||
| IFNG | interferon, gamma | 0.173 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.130 | ||
| CPE | carboxypeptidase E | 0.119 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.116 | Human | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.101 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.092 | ||
| CD83 | CD83 molecule | 0.088 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.087 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.081 | ||
| IL2RB | interleukin 2 receptor, beta | 0.078 | ||
| GNLY | granulysin | 0.069 | ||
| IL10 | interleukin 10 | 0.068 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.066 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.066 | Human | |
| CCL21 | chemokine (C-C motif) ligand 21 | 0.059 | ||
| SLAMF8 | SLAM family member 8 | 0.056 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.055 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.055 | ||
| SELE | selectin E | 0.047 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.045 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.042 | Human | |
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.041 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.038 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.037 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.036 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.035 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.033 | ||
| UBD | ubiquitin D | 0.033 | ||
| FPR3 | formyl peptide receptor 3 | 0.032 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.029 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.029 | ||
| RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 0.028 | ||
| DARC | Duffy blood group, chemokine receptor | 0.028 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.028 | ||
| BCL2A1 | BCL2-related protein A1 | 0.027 | ||
| TNF | tumor necrosis factor | 0.026 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.026 | Human | |
| IL10RA | interleukin 10 receptor, alpha | 0.025 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.024 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.024 | ||
| PLEK | pleckstrin | 0.024 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.023 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.022 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.021 | ||
| PRF1 | perforin 1 (pore forming protein) | 0.020 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.018 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.018 | ||
| NKG7 | natural killer cell group 7 sequence | 0.017 | ||
| IL7R | interleukin 7 receptor | 0.017 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.017 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.016 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.015 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.015 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.015 | ||
| SLAMF7 | SLAM family member 7 | 0.015 | ||
| C2 | complement component 2 | 0.014 | ||
| INHBA | inhibin, beta A | 0.014 | ||
| CD163 | CD163 molecule | 0.013 | ||
| IL32 | interleukin 32 | 0.013 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.012 | ||
| CH25H | cholesterol 25-hydroxylase | 0.012 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.012 | ||
| DPT | dermatopontin | 0.012 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.012 | ||
| CD86 | CD86 molecule | 0.011 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.011 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.011 | ||
| MARCO | macrophage receptor with collagenous structure | 0.011 |